Article Text

PDF

Treatment of experimental pulmonary embolism by main pulmonary arterial infusion of a fibrinolytic agent
  1. Danilo I. Magtira,
  2. M. Wells,
  3. R. Llamas,
  4. R. Clark,
  5. G. L. Baum
  1. Cardiopulmonary Laboratory, Veterans Administration Hospital, Coral Gables, Florida
  2. Department of Medicine, University of Miami School of Medicine, Miami, Florida

    Abstract

    The continuous instillation of plasmin (Thrombolysin) directly into the main pulmonary artery of greyhounds, using one half of the systemic doses, was found to be more effective in accelerating or enhancing in vivo lysis of artificially produced pulmonary emboli than systemic intravenous infusion. Animals which received direct pulmonary arterial instillations of Thrombolysin showed remarkably few macroemboli. By light microscopy, these clots showed zones of lysis mainly in the central portions of the clots. We suggest that the flow-guided catheterization of the main pulmonary artery used in this study on greyhounds can be applied to critically ill human subjects, as shown by earlier studies (Magtira, Winkler, Duprey, and Baum, 1966). Continuous infusions of thrombolytic agents directly into the main pulmonary artery might then offer an effective therapy for human pulmonary embolism, especially during that critical period following a massive or submassive embolic episode.

    Statistics from Altmetric.com

    Footnotes

    • 1 Portions of this paper were presented at the National Meeting (Pulmonary Section) of the American Federation for Clinical Research, Atlantic City, New Jersey, 30 April 1967

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.